A Phase 1 of CTX-8371 in Patients With Advanced Malignancies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies	Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, immune system disorder, immunoproliferative disorder, lung disorder, lung neoplasm, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, squamous cell carcinoma, triple-negative breast carcinoma	Recruiting	Phase 1	2026-07-28		NCT06150664

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Compass Therapeutics	6

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beth Israel Deaconess Medical Center	Boston	United States	462
D&H Cancer Research Center	Margate	United States	5
Dana-Farber Cancer Institute	Boston	United States	626
Florida Cancer Specialists - Lake Nona	Orlando	United States	5
Florida Cancer Specialists - Sarasota	Sarasota	United States	3
Fort Wayne Medical Oncology and Hematology	Fort Wayne	United States	22
Roswell Park Cancer Institute	Buffalo	United States	382
Summit Cancer Center	Spokane	United States	3
Tennessee Oncology	Nashville	United States	77
University Cancer & Blood Center	Athens	United States	5